HealthEquity (NASDAQ:HQY) Given New $129.00 Price Target at JPMorgan Chase & Co.

HealthEquity (NASDAQ:HQY) had its price target hoisted by JPMorgan Chase & Co. from $126.00 to $129.00 in a report released on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Several other analysts have also weighed in on HQY. Citizens Jmp boosted their target price on shares of HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a research note on Thursday. JMP Securities set a $122.00 price objective on shares of HealthEquity in a research note on Thursday. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. BMO Capital Markets started coverage on HealthEquity in a research report on Thursday, November 13th. They set a “market perform” rating and a $100.00 price target on the stock. Finally, Jefferies Financial Group raised their price target on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $120.07.

HealthEquity Price Performance

HQY opened at $95.67 on Thursday. HealthEquity has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a 50 day moving average of $96.41 and a two-hundred day moving average of $96.87. The company has a market cap of $8.24 billion, a P/E ratio of 43.89, a P/E/G ratio of 1.42 and a beta of 0.18. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.95% and a net margin of 14.86%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Activity

In other news, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the sale, the executive vice president owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. The trade was a 7.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 10,781 shares of company stock worth $1,016,707. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds have recently modified their holdings of the stock. Farther Finance Advisors LLC increased its holdings in shares of HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the period. WPG Advisers LLC purchased a new position in HealthEquity during the first quarter valued at approximately $28,000. True Wealth Design LLC increased its stake in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after buying an additional 317 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in HealthEquity in the 2nd quarter worth approximately $33,000. Finally, Cullen Frost Bankers Inc. lifted its position in HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after buying an additional 224 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.